Pneumococcal vaccination in adults: a review of the current recommendations

Mihălțan, Florin

doi:10.2478/pneum-2023-0010

Abstract

Pneumococcal disease remains a significant cause of morbidity and mortality, particularly in older adults and individuals with underlying medical conditions. To address this public health threat, pneumococcal vaccines have been developed and recommended for use in adult populations. This article provides a comprehensive review of the current recommendations for pneumococcal vaccination in adults and discusses the burden of pneumococcal disease in the adult population, including risk factors for developing the disease. The article concludes with a discussion about future directions for pneumococcal vaccination in adults, including the use of new and improved vaccines, which are developed to ensure wide protection against pneumococcal disease.

References

Said MA, Johnson HL, Nonyane BA, Deloria-Knoll M, O’Brien KL; AGEDD Adult Pneumococcal Burden Study Team, et al. Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques. PLoS One. 2013;8(4): e60273.
Search in Google Scholar Back to article
Huang SS, Johnson KM, Ray GT, Wroe P, Lieu TA, Moore MR, et al. Healthcare utilization and cost of pneumococcal disease in the United States. Vaccine. 2011;29(18): 3398–3412.
Search in Google Scholar Back to article
Corrado RE, Lee D, Lucero DE, Varma JK, Vora NM. Burden of adult community-acquired, health-care-associated, hospital-acquired, and ventilator-associated pneumonia: New York City, 2010 to 2014. Chest. 2017;152(5): 930–942.
Search in Google Scholar Back to article
Pelton SI, Shea KM, Bornheimer R, Sato R, Weycker D. Pneumonia in young adults with asthma: impact on subsequent asthma exacerbations. Journal of Asthma and Allergy. 2019;12: 95–99.
Search in Google Scholar Back to article
Bornheimer R, Shea KM, Sato R, Weycker D, Pelton SI. Risk of exacerbation following pneumonia in adults with heart failure or chronic obstructive pulmonary disease. PLoS One. 2017;12(10): e0184877.
Search in Google Scholar Back to article
Weycker D, Farkouh RA, Strutton DR, Edelsberg J, Shea KM, Pelton SI. Rates and costs of invasive pneumococcal disease and pneumonia in persons with underlying medical conditions. BioMed Central Health Services Research. 2016;16: 182.
Search in Google Scholar Back to article
Fleming D, Taylor RJ, Lustig RL, Schuck-Paim C, Haguinet F, Webb DJ, et al. Modelling estimates of the burden of respiratory syncytial virus infection in adults and the elderly in the United Kingdom. BMC Infectious Diseases. 2015; 15: 443.
Search in Google Scholar Back to article
Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. The New England Journal of Medicine. 2005;352(17): 1749–1759.
Search in Google Scholar Back to article
Caljouw MAA, Kruijdenberg SJM, de Craen AJM, Cools HJM, den Elzen WPJ, Gussekloo J. Clinically diagnosed infections predict disability in activities of daily living among the oldest-old in the general population: the Leiden 85-plus Study. Age and Ageing. 2013;42(4): 482–488.
Search in Google Scholar Back to article
Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289(2): 179–186.
Search in Google Scholar Back to article
Shoar S, Musher DM. Etiology of community-acquired pneumonia in adults: a systematic review. Pneumonia. 2020;12: 11.
Search in Google Scholar Back to article
Centers for Disease Control and Prevention. Pneumococcal disease. In: Hamborsky J, Kroger A, Wolfe S. (eds.) Epidemiology and prevention of vaccine-preventable diseases. 13th ed. Washington, DC: Public Health Foundation; 2015.p. 279–296.
Search in Google Scholar Back to article
Bewick T, Sheppard C, Greenwood S, Slack M, Trotter C, George R, et al. Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumonia. Thorax. 2012;67(6): 540–545.
Search in Google Scholar Back to article
Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax. 2012;67(1): 71–79.
Search in Google Scholar Back to article
Ishiguro T, Takayanagi N, Yamaguchi S, Yamakawa H, Nakamoto K, Takaku Y, et al. Etiology and factors contributing to the severity and mortality or community-acquired pneumonia. Internal Medicine. 2013;52(3): 317–324.
Search in Google Scholar Back to article
Shea KM, Edelsberg J, Weycker D, Farkouh RA, Strutton DR, Pelton SI. Rates of pneumococcal disease in adults with chronic medical conditions. Open Forum Infectious Diseases. 2014;1(1): ofu024.
Search in Google Scholar Back to article
Epidemiological analysis of pneumococcal disease in Romanian hospitals. In: Laszlo AS, Lorenzovici, Szabolcs Farkas-Ráduly. (eds.) National Conference of Pharmacoeconomics and Health Management. 8th ed. 14–17 October 2021, Brasov, Romania. Available from: https://www.researchgate.net/publication/355545934_Analiza_epidemiologica_privind_boala_pneumococica_in_spitalele_din_Romania. [Accessed 13 October 2022].
Search in Google Scholar Back to article
Pneumococcal Disease: Risk Factors and How it Spreads, CDC. Available from: https://www.cdc.gov/pneumococcal/about/risk-transmission.html [ Accessed February 2023].
Search in Google Scholar Back to article
Pelton SI. Pneumococcal vaccines: polysaccharide and conjugate. Current Opinion in Pediatrics. 2017;29(5): 577–582.
Search in Google Scholar Back to article
Golos M, Eliakim-Raz N, Stern A, Leibovici L, Paul M. Conjugated pneumococcal vaccine versus polysaccharide pneumococcal vaccine for prevention of pneumonia and invasive pneumococcal disease in immunocompetent and immunocompromised adults and children. The Cochrane Database of Systematic Reviews. 2019;2019(2): CD012306. doi:10.1002/14651858. CD012306.pub2.
Search in Google Scholar Back to article
Pneumococcal Vaccination I CDC. Available from: https://www.cdc.gov/vaccines/vpd/pneumo/index.html [Accessed February 2023].
Search in Google Scholar Back to article
Kobayashi M, Farrar JL, Gierke R, Britton A, Childs L, Leidner AJ, et al. Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among U.S. adults: updated recommendations of the advisory committee on immunization practices – United States, 2022. Morbidity and Mortality Weekly Report. 2022;71: 109–117. doi:10.15585/mmwr. mm7104a1.
Search in Google Scholar Back to article
Pneumococcal Vaccine Timing for Adults I CDC. Available from: https://www.cdc.gov/vaccines/vpd/pneumo/downloads/pneumovaccine-timing.pdf [Accessed February 2023].
Search in Google Scholar Back to article
Global strategy for prevention, diagnosis and management of COPD: 2023. Report. Available from: https://goldcopd.org/2023-gold-report-2/ [Accessed February 2023].
Search in Google Scholar Back to article
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Revista española de cardiología (English ed.). 2022;75(6): 523. English, Spanish. doi:10.1016/j.rec.2022.05.005. [ Accessed February 2023].
Search in Google Scholar Back to article
Standards of care in diabetes – 2023. Diabetes Care. 2023; 46(Supplement 1): S1–S292. American Diabetes Association. Available from: diabetesjournals.org
Search in Google Scholar Back to article
Mugwagwa T, Averin A, Atwood M, Sato R, Vyse A, Campling J, et al. Public health and budgetary impact of 20-valent pneumococcal conjugate vaccine for adults in England. Expert Review of Vaccines. 2022;21(9): 1331–1341. doi:10.1080/14760584.2022.2104250.
Search in Google Scholar Back to article
Apexxnar SmPC. Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed): Pfizer, 2022. Available from: https://www.ema.europa.eu/en/documents/product-information/apexxnar-epar-product-information_en.pdf [Accessed February 2023].
Search in Google Scholar Back to article

Pneumococcal vaccination in adults: a review of the current recommendations

Abstract

Paradigm

My account